Preliminary study shows potential of Manuka honey as a nutraceutical for breast cancer
A study found that methyl syringate is a primary driving factor in Manuka honey's ability to ameliorate neutrophil intracellular ROS activity and NETosis, making it a promising therapeutic agent for various inflammatory conditions.